A30T (p.Ala30Thr) variant of CDH2 (Cadherin-2)

A30T (p.Ala30Thr) in CDH2 (Cadherin-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.23 / 1. The record also includes population frequency data and structural context.

A30T (p.Ala30Thr) variant details